Advertisement
Australia markets closed
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • AUD/USD

    0.6453
    +0.0002 (+0.03%)
     
  • ASX 200

    7,683.50
    +34.30 (+0.45%)
     
  • OIL

    81.33
    -0.57 (-0.70%)
     
  • GOLD

    2,315.10
    -31.30 (-1.33%)
     
  • Bitcoin AUD

    102,255.63
    +193.45 (+0.19%)
     
  • CMC Crypto 200

    1,420.60
    +5.84 (+0.41%)
     

Why Bluebird Bio Stock Is Sinking This Week

Why Bluebird Bio Stock Is Sinking This Week

Shares of the gene therapy pioneer Bluebird Bio (NASDAQ: BLUE) have been under heavy pressure this week. Investors hit the exits after the company revealed that it may miss the first-quarter submission goal for lovo-cel's Biologics License Application (BLA) to the Food and Drug Administration (FDA). Lovo-cel is an experimental gene therapy in development for the rare blood disorder sickle cell disease.